Skip Nav Destination
1-20 of 33
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Growth pattern and clinical correlation of subcutaneously inoculated human primary acute leukemias in severe combined immunodeficiency mice
Y Yan, O Salomon, J McGuirk, D Dennig, J Fernandez, C Jagiello, H Nguyen, N Collins, P Steinherz, RJ O'Reilly
Blood (1996) 88 (8): 3137–3146.
The development of cellular immunity to Epstein-Barr virus after allogeneic bone marrow transplantation
Blood (1996) 87 (6): 2594–2603.
Selective treatment of SCID mice bearing methotrexate-transport- resistant human acute lymphoblastic leukemia tumors with trimetrexate and leucovorin protection
Blood (1995) 85 (10): 2675–2679.
Granulocyte colony-stimulating factor (CSF) but not interleukin-1 (IL- 1), IL-3, and granulocyte-macrophage CSF protect bone marrow progenitor cells from suppression by allosensitized cytotoxic T cells
Blood (1994) 84 (6): 1906–1912.
Minimal residual disease is more common in patients who have mixed T- cell chimerism after bone marrow transplantation for chronic myelogenous leukemia
Blood (1994) 83 (11): 3409–3416.
AP Gillio, LB Faulkner, BP Alter, L Reilly, R Klafter, G Heller, DC Young, JM Lipton, MA Moore, RJ O'Reilly
Blood (1993) 82 (3): 744–751.
Effect of stem cell factor on in vitro erythropoiesis in patients with bone marrow failure syndromes
Blood (1992) 80 (12): 3000–3008.
Myeloid and lymphoid chimerism after T-cell-depleted bone marrow transplantation: evaluation of conditioning regimens using the polymerase chain reaction to amplify human minisatellite regions of genomic DNA
Blood (1992) 80 (12): 3235–3241.
Clonal analysis of myelodysplastic syndrome: monosomy 7 is expressed in the myeloid lineage, but not in the lymphoid lineage as detected by fluorescent in situ hybridization
WR Gerritsen, J Donohue, J Bauman, SC Jhanwar, NA Kernan, H Castro-Malaspina, RJ O'Reilly, JH Bourhis
Blood (1992) 80 (1): 217–224.
Blood (1991) 77 (10): 2122–2128.
B-cell differentiation following autologous, conventional, or T-cell depleted bone marrow transplantation: a recapitulation of normal B-cell ontogeny
Blood (1990) 76 (8): 1647–1656.
Anti-leukemia potential of interleukin-2 activated natural killer cells after bone marrow transplantation for chronic myelogenous leukemia
M Hauch, MV Gazzola, T Small, C Bordignon, L Barnett, I Cunningham, H Castro- Malaspinia, RJ O'Reilly, CA Keever
Blood (1990) 75 (11): 2250–2262.
Cytogenetic analysis of chimerism and leukemia relapse in chronic myelogenous leukemia patients after T cell-depleted bone marrow transplantation
Blood (1990) 75 (6): 1346–1355.
Graft failure after T-cell-depleted human leukocyte antigen identical marrow transplants for leukemia: II. In vitro analyses of host effector mechanisms
Blood (1989) 74 (6): 2237–2243.
Effects of interleukin-1 on hematopoietic progenitors: evidence of stimulatory and inhibitory activities in a primate model
Blood (1989) 74 (2): 547–550.
Immune reconstitution following bone marrow transplantation: comparison of recipients of T-cell depleted marrow with recipients of conventional marrow grafts
CA Keever, TN Small, N Flomenberg, G Heller, K Pekle, P Black, A Pecora, A Gillio, NA Kernan, RJ O'Reilly
Blood (1989) 73 (5): 1340–1350.
Interleukin 2-activated killer cells in patients following transplants of soybean lectin-separated and E rosette-depleted bone marrow
Blood (1987) 70 (6): 1893–1903.
Host origin of the human hematopoietic microenvironment following allogeneic bone marrow transplantation
Blood (1987) 70 (6): 1966–1968.
Interleukin-2 production and response to interleukin-2 by peripheral blood mononuclear cells from patients after bone marrow transplantation: II. Patients receiving soybean lectin-separated and T cell-depleted bone marrow
Blood (1987) 70 (5): 1595–1603.
Clonable T lymphocytes in T cell-depleted bone marrow transplants correlate with development of graft-v-host disease
Blood (1986) 68 (3): 770–773.